{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:56:41Z","timestamp":1784318201510,"version":"3.55.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81771449"],"award-info":[{"award-number":["81771449"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Research and Development Projects in Anhui Province","award":["1804h08020263"],"award-info":[{"award-number":["1804h08020263"]}]},{"name":"Scientific Research Foundation of the Institute for Translational Medicine","award":["2017zhyx17"],"award-info":[{"award-number":["2017zhyx17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Schizophrenia patients with a metabolically abnormal obese (MAO) phenotype have been shown poor cardiovascular outcomes, but the characteristics of their current psychiatric symptoms have not been characterized. This study mainly explored the psychiatric symptoms of schizophrenia patients with the MAO phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A total of 329 patients with schizophrenia and 175 sex- and age-matched people without schizophrenia from Anhui Province in China were enrolled. The Positive and Negative Syndrome Scale (PANSS) was used to evaluate the mental symptoms of the schizophrenia patients. The MAO phenotype was defined as meeting 1\u20134 metabolic syndrome criteria (excluding waist circumference) and having a body mass index (BMI)\u2009\u2265\u200928\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . And, metabolically healthy normal-weight (MHNW) phenotype was defined as meeting 0 criteria for metabolic syndrome and 18.5\u2009\u2264\u2009BMI\u2009&lt;\u200924\u2009kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 15.8% of the schizophrenia patients and 9.1% of the control group were consistent with the MAO phenotype, and the prevalence of MAO in the schizophrenia group was higher than that in the control group. Among the patients with schizophrenia, the MAO group had lower negative factor, cognitive factor and total PANSS scores than the MHNW group. However, when confounding factors were controlled, only the negative factor remained lower significantly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found that schizophrenia patients with the MAO phenotype had reduced negative symptoms, which may indicate an internal mechanism linking metabolic disorders and negative symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      This study was registered in the China Clinical Trial Registration Center (No. chiCTR\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=27123\">1,800,017,044<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-020-02809-4","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T08:03:21Z","timestamp":1597737801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms"],"prefix":"10.1186","volume":"20","author":[{"given":"Juan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuai","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-5249","authenticated-orcid":false,"given":"Huanzhong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"2809_CR1","volume-title":"Schizophrenia","author":"World Health Organization","year":"2016","unstructured":"World Health Organization, 2016. Schizophrenia. http:\/\/www.who.int\/mediacentre\/factsheets\/fs397\/en\/. Accessed 6 Mar 2017."},{"key":"2809_CR2","doi-asserted-by":"crossref","first-page":"d5422","DOI":"10.1136\/bmj.d5422","volume":"343","author":"U Hoang","year":"2011","unstructured":"Hoang U, Stewart R, Goldacre MJ. Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006. Bmj. 2011;343:d5422.","journal-title":"Bmj"},{"key":"2809_CR3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eurpsy.2017.05.022","volume":"45","author":"I Bitter","year":"2017","unstructured":"Bitter I, Czobor P, Borsi A, Feher L, Nagy BZ, Bacskai M, et al. Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study. Eur Psychiatry. 2017;45:97\u2013103.","journal-title":"Eur Psychiatry"},{"key":"2809_CR4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-clinpsy-032813-153657","volume":"10","author":"TM Laursen","year":"2014","unstructured":"Laursen TM, Nordentoft M, Mortensen PB. Excess early mortality in schizophrenia. Annu Rev Clin Psychol. 2014;10:425\u201348.","journal-title":"Annu Rev Clin Psychol"},{"issue":"2","key":"2809_CR5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.bp.109.067512","volume":"196","author":"S Brown","year":"2010","unstructured":"Brown S, Mmitchell K. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry. 2010;196(2):116\u201321.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"2809_CR6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5694\/mja16.00650","volume":"206","author":"L Kritharides","year":"2017","unstructured":"Kritharides L, Chow V, Lambert TJ. Cardiovascular disease in patients with schizophrenia. Med J Aust. 2017;206(2):91\u20135.","journal-title":"Med J Aust"},{"issue":"12","key":"2809_CR7","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry. 2015;72(12):1172\u201381.","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"2809_CR8","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","volume":"118","author":"FB Ortega","year":"2016","unstructured":"Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118(11):1752\u201370.","journal-title":"Circ Res"},{"issue":"1","key":"2809_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2217\/bmm.11.105","volume":"6","author":"CJ Roos","year":"2012","unstructured":"Roos CJ, Quax PH, Jukema JW. Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease. Biomark Med. 2012;6(1):35\u201352.","journal-title":"Biomark Med"},{"issue":"12","key":"2809_CR10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1053\/meta.2001.27213","volume":"50","author":"EA Sims","year":"2001","unstructured":"Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism. 2001;50(12):1499\u2013504.","journal-title":"Metabolism"},{"issue":"6","key":"2809_CR11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S1262-3636(07)70156-8","volume":"30","author":"AD Karelis","year":"2004","unstructured":"Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab. 2004;30(6):569\u201372.","journal-title":"Diabetes Metab"},{"issue":"5","key":"2809_CR12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/eurheartj\/ehs174","volume":"34","author":"FB Ortega","year":"2013","unstructured":"Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J. 2013;34(5):389\u201397.","journal-title":"Eur Heart J"},{"issue":"1","key":"2809_CR13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pcad.2015.05.001","volume":"58","author":"FB Ortega","year":"2015","unstructured":"Ortega FB, Cadenas-Sanchez C, Sui X, Blair SN, Lavie CJ. Role of fitness in the metabolically healthy but obese phenotype: a review and update. Prog Cardiovasc Dis. 2015;58(1):76\u201386.","journal-title":"Prog Cardiovasc Dis"},{"issue":"8","key":"2809_CR14","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.2337\/dc07-0419","volume":"30","author":"MA Marini","year":"2007","unstructured":"Marini MA, Succurro E, Frontoni S, Hribal ML, Andreozzi F, Lauro R, et al. Metabolically healthy but obese women have an intermediate cardiovascular risk profile between healthy nonobese women and obese insulin-resistant women. Diabetes Care. 2007;30(8):2145\u20137.","journal-title":"Diabetes Care"},{"issue":"12","key":"2809_CR15","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","volume":"70","author":"R Caleyachetty","year":"2017","unstructured":"Caleyachetty R, Thomas GN, Toulis KA, Mohammed N, Gokhale KM, Balachandran K, et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women. J Am Coll Cardiol. 2017;70(12):1429\u201337.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"2809_CR16","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/ijo.2016.114","volume":"40","author":"YM Park","year":"2016","unstructured":"Park YM, Steck SE, Fung TT, Zhang J, Hazlett LJ, Han K, et al. Mediterranean diet and mortality risk in metabolically healthy obese and metabolically unhealthy obese phenotypes. Int J Obes. 2016;40(10):1541\u20139.","journal-title":"Int J Obes"},{"issue":"1","key":"2809_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2014.11.008","volume":"25","author":"P Goncalves","year":"2015","unstructured":"Goncalves P, Araujo JR, Martel F. Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms. Eur Neuropsychopharmacol. 2015;25(1):1\u201316.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"2809_CR18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40266-014-0152-x","volume":"31","author":"MD Guenette","year":"2014","unstructured":"Guenette MD, Chintoh A, Remington G, Hahn M. Atypical antipsychotic-induced metabolic disturbances in the elderly. Drugs Aging. 2014;31(3):159\u201384.","journal-title":"Drugs Aging"},{"issue":"4","key":"2809_CR19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3928\/02793695-20180108-05","volume":"56","author":"G Dikec","year":"2018","unstructured":"Dikec G, Arabaci LB, Uzunoglu GB, Mizrak SD. Metabolic side effects in patients using atypical antipsychotic medications during hospitalization. J Psychosoc Nurs Ment Health Serv. 2018;56(4):28\u201337.","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"2809_CR20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1471-244X-14-184","volume":"14","author":"N Sugawara","year":"2014","unstructured":"Sugawara N, Yasui-Furukori N, Sato Y, Saito M, Furukori H, Nakagami T, et al. Dietary patterns are associated with obesity in Japanese patients with schizophrenia. BMC Psychiatry. 2014;14:184.","journal-title":"BMC Psychiatry"},{"issue":"10","key":"2809_CR21","doi-asserted-by":"crossref","first-page":"e1277","DOI":"10.4088\/JCP.14m09330","volume":"76","author":"CA Janney","year":"2015","unstructured":"Janney CA, Ganguli R, Tang G, Cauley JA, Holleman RG, Richardson CR, et al. Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders. J Clin Psychiatry. 2015;76(10):e1277\u201384.","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"2809_CR22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-0447.2010.01666.x","volume":"123","author":"D Vancampfort","year":"2011","unstructured":"Vancampfort D, Probst M, Sweers K, Maurissen K, Knapen J, De Hert M. Relationships between obesity, functional exercise capacity, physical activity participation and physical self-perception in people with schizophrenia. Acta Psychiatr Scand. 2011;123(6):423\u201330.","journal-title":"Acta Psychiatr Scand"},{"issue":"17","key":"2809_CR23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1080\/14656566.2017.1401608","volume":"18","author":"T Si","year":"2017","unstructured":"Si T, Zhuo J, Turkoz I, Mathews M, Tan W, Feng Y. Once-monthly injection of paliperidone palmitate in patients with recently diagnosed and chronic schizophrenia: a post-hoc comparison of efficacy and safety. Expert Opin Pharmacother. 2017;18(17):1799\u2013809.","journal-title":"Expert Opin Pharmacother"},{"key":"2809_CR24","volume-title":"The Asia-Pacific perspective: Redefining obesity and its treatment","author":"World Health Organization International Association for the Study of Obesity, International Obesity TaskForce","year":"2000","unstructured":"World Health Organization International Association for the Study of Obesity, International Obesity TaskForce. The Asia-Pacific perspective: Redefining obesity and its treatment. Melbourne: Health Communications; 2000."},{"issue":"s8","key":"2809_CR25","first-page":"S685","volume":"11","author":"BF Zhou","year":"2002","unstructured":"Zhou BF. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults - study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 2002;11(s8):S685\u2013S93.","journal-title":"Biomed Environ Sci"},{"issue":"16","key":"2809_CR26","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"KG Alberti","year":"2009","unstructured":"Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; world heart federation; international atherosclerosis society; and International Association for the Study of obesity. Circulation. 2009;120(16):1640\u20135.","journal-title":"Circulation"},{"issue":"2","key":"2809_CR27","first-page":"240","volume":"18","author":"CX Zhang","year":"2009","unstructured":"Zhang CX, Ho SC. Validity and reproducibility of a food frequency questionnaire among Chinese women in Guangdong province. Asia Pac J Clin Nutr. 2009;18(2):240\u201350.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"2","key":"2809_CR28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/sj.ijo.0800772","volume":"23","author":"A Molarius","year":"1999","unstructured":"Molarius A, Seidell JC, Sans S, Tuomilehto J, Kuulasmaa K. Waist and hip circumferences, and waist-hip ratio in 19 populations of the WHO MONICA project. Int J Obes Relat Metab Disord. 1999;23(2):116\u201325.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2809_CR29","volume-title":"Clinical Pharmacy Pocket Companion","author":"J Wright","year":"2015","unstructured":"Wright J, Gray A, Bruce L. Clinical Pharmacy Pocket Companion; 2015."},{"issue":"7","key":"2809_CR30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"12","key":"2809_CR31","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/dc09-0574","volume":"32","author":"JL Kuk","year":"2009","unstructured":"Kuk JL, Ardern CI. Are metabolically normal but obese individuals at lower risk for all-cause mortality? Diabetes Care. 2009;32(12):2297\u20139.","journal-title":"Diabetes Care"},{"issue":"2","key":"2809_CR32","first-page":"261","volume":"13","author":"SR Kay","year":"1986","unstructured":"Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1986;13(2):261\u201376.","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"2809_CR33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","volume":"137","author":"RS Wallwork","year":"2012","unstructured":"Wallwork RS, Fortgang R, Hashimoto R, Weinberger DR, Dickinson D. Searching for a consensus five-factor model of the positive and negative syndrome scale for schizophrenia. Schizophr Res. 2012;137(1\u20133):246\u201350.","journal-title":"Schizophr Res"},{"issue":"2","key":"2809_CR34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2015.07.040","volume":"242","author":"CM Phillips","year":"2015","unstructured":"Phillips CM, Perry IJ. Lipoprotein particle subclass profiles among metabolically healthy and unhealthy obese and non-obese adults: does size matter? Atherosclerosis. 2015;242(2):399\u2013406.","journal-title":"Atherosclerosis"},{"issue":"6","key":"2809_CR35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2014.08.005","volume":"40","author":"S Chen","year":"2014","unstructured":"Chen S, Zhou S, Wu B, Zhao Y, Liu X, Liang Y, et al. Association between metabolically unhealthy overweight\/obesity and chronic kidney disease: the role of inflammation. Diabetes Metab. 2014;40(6):423\u201330.","journal-title":"Diabetes Metab"},{"issue":"Suppl 1","key":"2809_CR36","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005;19(Suppl 1):1\u201393.","journal-title":"CNS Drugs"},{"issue":"2","key":"2809_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","volume":"17","author":"CU Correll","year":"2011","unstructured":"Correll CU, Lencz T, Malhotra AK. Antipsychotic drugs and obesity. Trends Mol Med. 2011;17(2):97\u2013107.","journal-title":"Trends Mol Med"},{"issue":"3","key":"2809_CR38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pharmthera.2010.04.008","volume":"127","author":"R Coccurello","year":"2010","unstructured":"Coccurello R, Moles A. Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design. Pharmacol Ther. 2010;127(3):210\u201351.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2809_CR39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M De Hert","year":"2011","unstructured":"De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011;8(2):114\u201326.","journal-title":"Nat Rev Endocrinol"},{"issue":"2 Suppl 1","key":"2809_CR40","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/j.dsx.2016.01.032","volume":"10","author":"DD Pratyush","year":"2016","unstructured":"Pratyush DD, Tiwari S, Singh S, Singh SK. Risk factors of diabetes in north Indians with metabolic syndrome. Diabetes Metab Syndr. 2016;10(2 Suppl 1):S68\u201371. https:\/\/doi.org\/10.1016\/j.dsx.2016.01.032.","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"2809_CR41","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/dc12-1805","volume":"36","author":"R Taylor","year":"2013","unstructured":"Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36(4):1047\u201355. https:\/\/doi.org\/10.2337\/dc12-1805.","journal-title":"Diabetes Care"},{"issue":"3\u20134","key":"2809_CR42","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00424-017-1955-5","volume":"469","author":"MA Lauterbach","year":"2017","unstructured":"Lauterbach MA, Wunderlich FT. Pflugers Arch. 2017;469(3\u20134):385\u201396. https:\/\/doi.org\/10.1007\/s00424-017-1955-5.","journal-title":"Pflugers Arch"},{"issue":"16","key":"2809_CR43","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1161\/01.cir.0000035280.64322.31","volume":"106","author":"HN Ginsberg","year":"2002","unstructured":"Ginsberg HN. New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism. Circulation. 2002;106(16):2137\u201342. https:\/\/doi.org\/10.1161\/01.cir.0000035280.64322.31.","journal-title":"Circulation"},{"issue":"1","key":"2809_CR44","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1080\/07853890500415358","volume":"38","author":"E Ferrannini","year":"2006","unstructured":"Ferrannini E. Is insulin resistance the cause of the metabolic syndrome? Ann Med. 2006;38(1):42\u201351. https:\/\/doi.org\/10.1080\/07853890500415358.","journal-title":"Ann Med"},{"issue":"4","key":"2809_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s001250050919","volume":"41","author":"H Yki-Jarvinen","year":"1998","unstructured":"Yki-Jarvinen H, Utriainen T. Insulin-induced vasodilatation: physiology or pharmacology? Diabetologia. 1998;41(4):369\u201379. https:\/\/doi.org\/10.1007\/s001250050919.","journal-title":"Diabetologia"},{"key":"2809_CR46","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2017.04.002","volume":"192","author":"G Mezquida","year":"2018","unstructured":"Mezquida G, Savulich G, Garcia-Rizo C, Garcia-Portilla MP, Toll A, Garcia-Alvarez L, et al. Inverse association between negative symptoms and body mass index in chronic schizophrenia. Schizophr Res. 2018;192:69\u201374.","journal-title":"Schizophr Res"},{"key":"2809_CR47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fpsyt.2019.00251","volume":"10","author":"V Soontornniyomkij","year":"2019","unstructured":"Soontornniyomkij V, Lee EE, Jin H, Martin AS, Daly RE, Liu J, et al. Clinical correlates of insulin resistance in chronic schizophrenia: relationship to negative symptoms. Front Psychiatry. 2019;10:251.","journal-title":"Front Psychiatry"},{"issue":"10202","key":"2809_CR48","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939\u201351.","journal-title":"Lancet"},{"issue":"1","key":"2809_CR49","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12888-018-1872-y","volume":"18","author":"R Roberts","year":"2018","unstructured":"Roberts R, Neasham A, Lambrinudi C, Khan A. A thematic analysis assessing clinical decision-making in antipsychotic prescribing for schizophrenia. BMC Psychiatry. 2018;18(1):290. https:\/\/doi.org\/10.1186\/s12888-018-1872-y.","journal-title":"BMC Psychiatry"},{"issue":"3","key":"2809_CR50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.eurpsy.2013.04.003","volume":"29","author":"SF Chen","year":"2014","unstructured":"Chen SF, Hu TM, Lan TH, Chiu HJ, Sheen LY, Loh EW. Severity of psychosis syndrome and change of metabolic abnormality in chronic schizophrenia patients: severe negative syndrome may be related to a distinct lipid pathophysiology. Eur Psychiatry. 2014;29(3):167\u201371.","journal-title":"Eur Psychiatry"},{"issue":"12","key":"2809_CR51","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jamapsychiatry.2015.2196","volume":"72","author":"J Radua","year":"2015","unstructured":"Radua J, Schmidt A, Borgwardt S, Heinz A, Schlagenhauf F, McGuire P, et al. Ventral striatal activation during reward processing in psychosis: a Neurofunctional meta-analysis. JAMA Psychiatry. 2015;72(12):1243\u201351.","journal-title":"JAMA Psychiatry"},{"key":"2809_CR52","doi-asserted-by":"crossref","first-page":"16020","DOI":"10.1038\/npjschz.2016.20","volume":"2","author":"M Kirschner","year":"2016","unstructured":"Kirschner M, Hager OM, Bischof M, Hartmann-Riemer MN, Kluge A, Seifritz E, et al. Deficits in context-dependent adaptive coding of reward in schizophrenia. NPJ Schizophr. 2016;2:16020.","journal-title":"NPJ Schizophr"},{"issue":"4","key":"2809_CR53","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3945\/an.115.008268","volume":"6","author":"H Ziauddeen","year":"2015","unstructured":"Ziauddeen H, Alonso-Alonso M, Hill JO, Kelley M, Khan NA. Obesity and the neurocognitive basis of food reward and the control of intake. Adv Nutr. 2015;6(4):474\u201386.","journal-title":"Adv Nutr"},{"key":"2809_CR54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bandc.2015.10.001","volume":"110","author":"S Schiff","year":"2016","unstructured":"Schiff S, Amodio P, Testa G, Nardi M, Montagnese S, Caregaro L, et al. Impulsivity toward food reward is related to BMI: evidence from intertemporal choice in obese and normal-weight individuals. Brain Cogn. 2016;110:112\u20139.","journal-title":"Brain Cogn"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02809-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-020-02809-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-020-02809-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T19:38:12Z","timestamp":1629229092000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-020-02809-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2809"],"URL":"https:\/\/doi.org\/10.1186\/s12888-020-02809-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-15825\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-15825\/v1","asserted-by":"object"}]},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"21 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been approved by the Medical Ethics Committee of Chaohu Hospital of Anhui Medical University (No. 201805-kyxm-03). All participants or their guardians signed an informed consent form. Details that might disclose the identity of the subjects under study were omitted.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}